Christensen Mikkel B, Petersen Kasper M, Bøgevig Søren, Al-Gibouri Salam, Jimenez-Solem Espen, Dalhoff Kim P, Petersen Tonny S, Andersen Jon T
Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, DK-2400, Copenhagen, Denmark.
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
BMC Pharmacol Toxicol. 2018 Nov 27;19(1):78. doi: 10.1186/s40360-018-0271-9.
Calcium channel blockers (CCBs) are widely used drugs that have a narrow therapeutic index. Even minor overdoses must be treated in-hospital due to the risk of severe hypotension and bradycardia. We aimed to describe trends in CCB use and overdoses in Denmark.
Data on enquiries concerning CCBs reported to the Danish Poisons Information Center (DPIC) from January 2009 to January 2015 was coupled with data on hospitalization and mortality obtained from Danish National Registers. We obtained data on the general use of CCBs in Denmark and retrieved medical charts on fatal cases.
From a total of 126,987 enquiries to the DPIC in 2009-2014 we identified 339 CCB unique exposures (3‰ of all). Children < 5 years accounted for 20% all exposures and these were classified as 'intake during playing' (61%) and 'medication errors' (39%). Among adults 'suicidal poisonings' (58%), and 'medication errors' (34%) were most frequent. A majority (81%) of exposures led to hospital admission. Seven patients (2%) died from the CCB exposure and all were adults with 'suicidal poisoning'. Amlodipine accounted for 95% of all CCB prescriptions, was involved in 71% of enquiries and in 29% of fatalities. Verapamil accounted for 3% of prescriptions, was involved in 13% of enquiries and 57% of fatalities.
Four fifths of enquiries to the DPIC result in hospitalization and one fifth concern small children. Mortality were infrequent and occurred only in adults with suicidal exposures and with and an overrepresentation of verapamil exposures.
钙通道阻滞剂(CCB)是广泛使用的药物,治疗指数较窄。由于存在严重低血压和心动过缓的风险,即使是轻微过量服用也必须住院治疗。我们旨在描述丹麦CCB的使用和过量服用趋势。
将2009年1月至2015年1月向丹麦毒物信息中心(DPIC)报告的有关CCB的咨询数据与从丹麦国家登记处获得的住院和死亡数据相结合。我们获取了丹麦CCB的一般使用数据,并检索了死亡病例的病历。
在2009 - 2014年向DPIC的总共126,987次咨询中,我们确定了339例CCB独特暴露病例(占所有病例的3‰)。5岁以下儿童占所有暴露病例的20%,这些暴露被分类为“玩耍时摄入”(61%)和“用药错误”(39%)。在成年人中,“自杀性中毒”(58%)和“用药错误”(34%)最为常见。大多数(81%)暴露导致住院。7名患者(2%)因CCB暴露死亡,且均为患有“自杀性中毒”的成年人。氨氯地平占所有CCB处方的95%,涉及71%的咨询和29%的死亡病例。维拉帕米占处方的3%,涉及13%的咨询和57%的死亡病例。
向DPIC咨询的病例中有五分之四导致住院,五分之一涉及幼儿。死亡率很低,仅发生在有自杀性暴露的成年人中,且维拉帕米暴露的比例过高。